SecBot SecBot

GCGR

General Catalyst Global Resilience Merger Corp.
Nasdaq· CIK 0002108962
$10.00 +0.00 (+0.00%)
Oct 26 4:00 PM ET · prev $10.00
Since first trade
−2.2%
from $10.22 · Jun 22
30 days
−1.2%
from $10.12
Range since listing
$9.96–10.22
−2% from high · low Oct 21
Avg volume 20D
77.3K
Oct 23 spike 394.1K
Short interest
🔒 Subscribers only
New fund stakes
3
Q2 2026 13F · 0 exits
Filing reports
2
analyzed by SecBot
SecBot read MIXED 2 reports · latest
Balance 0 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 2/2
Strongest NEUTRAL General Catalyst Global Resilience Merger Corp. (GCGR) completed its IPO of 35,000,000 GRAIL securities at…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsBULLISH

    Q2 2026: 3 added (3 new), 0 trimmed or exited. Largest new: Adage Capital Partners Gp, L.L.C $31.8M, Magnetar Financial $25.2M.

  • TrendDOWNTREND

    1% below its 50-day average. New closing low $9.96 on Oct 21.

Who's buying

13F· Q2 2026
3
new positions
0
exits
$80.2M
in new stakes
FundMoveSharesValue
ADAGE CAPITAL PARTNERS GP, L.L.C.NEW3,150,000$31.8M
Magnetar Financial LLCNEW2,500,000$25.2M
Sculptor Capital LPNEW2,300,000$23.2M

Quarterly 13F filings are due 45 days after each quarter ends.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Jun 27, 2026
Trial readout
Results Pending: Glucose Tolerance Study (Phase 2) — Completed 86d ago
Trial: Glucose Tolerance Study Sponsor: RDC Clinical Pty Ltd Phase: Phase 2 | Completed: 2026-04-02 Conditions: Healthy Volunteers, Glucose…

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Jun 30, 2026 Inst.
ADAGE CAPITAL PARTNERS GP, — NEW
3,150,000 shares ($31.8M)
Jun 30, 2026 Inst.
Magnetar Financial LLC — NEW
2,500,000 shares ($25.2M)
Jun 27, 2026 Clinical trial readout
Results Pending: Glucose Tolerance Study (Phase 2) — Completed 86d ago
Trial: Glucose Tolerance Study Sponsor: RDC Clinical Pty Ltd Phase: Phase 2 | Completed: 2026-04-02
Apr 30, 2026 SEC
General Catalyst Global Resilience Merger Corp. (GCGR) completed its IPO of 35,000,000 GRAIL securities at $10.00 per…
424B4 — Impact 5/10
Apr 29, 2026 SEC
Four directors and officers of General Catalyst Global Resilience Merger Corp. (GCGR), a blank-check SPAC, filed…
3 — Impact 2/10

SecBot reports

2 filings · 0 bullish · 0 bearish · 2 neutral
All GCGR filing & press-release reports (2)